Cas No. 21172-41-8, 3-(3-TRIFLUOROMETHYL) PHENYL) PROPANAL

Cinacalcet, a calcimimetic agent, has shown exceptional efficacy in treating conditions such as primary hyperparathyroidism and secondary hyperparathyroidism in patients with chronic kidney disease. Collaborate with us to access top-notch intermediates, ensuring a streamlined production process and timely delivery of this transformative drug. Seize this opportunity to revolutionize parathyroid disorder treatment with Cinacalcet and make a difference in patients' lives.